StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Goldman Sachs Reiterates Buy Rating on Amgen (AMGN) After ESMO Data
September 30, 2019 8:29 AM
Goldman Sachs analyst Terence Flynn reiterated a Buy rating and $243.00 price target on Amgen (NASDAQ: AMGN) after the company ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments